Exchange: NASDAQ·Updated 12:34 PM EDT
VRTX logo

VRTX Vertex Pharmaceuticals, Inc.

$551.92
$4.27
(0.78%)
Today
Reported EarningsAug 3
Mkt Cap$138.81B
Vol676,299.00

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
30

Bearish Sentiment

How do you feel about VRTX?

Advertisement|Remove ads.